| Typicality: | 0.488 |
| Saliency: | 0.331 |
| in the development of secondary lymphedema | 10 | transitive-object |
| in breast cancer risk | 3 | other |
| in addiction | 2 | location |
| gene → be believed to play → role | 17 |
| gene → be suspected to play → role | 6 |
| gene → be suspected to have → role | 3 |
| gene → be believed to play → important role | 3 |
| negative | neutral | positive |
| 0.243 | 0.661 | 0.097 |
| Raw frequency | 29 |
| Normalized frequency | 0.331 |
| Modifier score | 0.800 |
| Perplexity | 29.248 |